Lipid-lowering Therapy and Goal Achievement in High-risk Patients From French General Practice

Author:

Ferrières Jean,Gorcyca Katherine,Iorga Şerban R.,Ansell David,Steen Dylan L.

Funder

Sanofi and Regeneron Pharmaceuticals, Inc

Publisher

Elsevier BV

Subject

Pharmacology (medical),Pharmacology

Reference33 articles.

1. World Health Organization. Noncommunicable diseases country profiles 2014: France. 2014. Available at: http://www.who.int/nmh/countries/fra_en.pdf.

2. Wilkins E, Wilson L, Wickramasinghe K, et al. European cardiovascular disease statistics 2017. Available at: http://www.ehnheart.org/cvd-statistics.html.

3. [Epidemiology of acute coronary syndromes in France and in Europe];Danchin;Ann Cardiol Angeiol (Paris),2010

4. ESC/EAS guidelines for the management of dyslipidaemias: the Task Force for the management of dyslipidaemias of the European Society of Cardiology (ESC) and the European Atherosclerosis Society (EAS);Reiner;Eur Heart J,2011

5. Haute Autorité de Santé. Bon usage des médicaments: prévention cardio-vasculaire: le choix de la statine la mieux adaptée dépend de son efficacité et de son efficience. 2012. Available at:https://www.has-sante.fr/portail/upload/docs/application/pdf/2012-02/statine_-_fiche_bum.pdf.

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3